KIMBERLY LABORDE: Open Payments
NPI 1902117781 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,421 in 137 payments from 26 companies in 2025. Trend: 2023 $2,275 · 2024 $3,357 · 2025 $5,421
Speaker / faculty: $3,150Food & beverage: $2,240Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $3,982 |
| GENZYME CORPORATION | 17 | $363 |
| PFIZER INC. | 9 | $151 |
| Janssen Biotech, Inc. | 8 | $130 |
| Lilly USA, LLC | 4 | $91 |
| UCB, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Novo Nordisk Inc | 3 | $58 |
| LEO Pharma Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
Products named: RINVOQ, DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, QULIPTA, VRAYLAR, Bimzelx.
Industry payments across LA — which companies pay providers there.
